The study investigates the use of high-flow oxygen therapy devices in patients at higher risk of complications during sedated digestive endoscopies. Sedation controlled by the endoscopist improves patient tolerance and facilitates higher-quality procedures, but it can have side effects such as hypoxemia or respiratory depression, especially in patients with sleep apnea, obesity, lung diseases, those over 60 years old, or with a history of sedation complications. While preventive measures, such as oxygen administration, are taken, the study aims to compare the effectiveness of new high-flow oxygen therapy devices with conventional nasal cannulas to improve safety during endoscopies.
No linked publications found in PubMed
Inclusion Criteria: * Be ≥ 18 years old * Sign the Informed Consent * Obesity (BMI ≥ 30 kg/m²) * ASA III * Stable pulmonary disease (no hospitalization in the last 6 months) * Stable heart failure (no hospitalization in the last 6 months) * Diagnosed or suspected obstructive sleep apnea with a score ≥ 3 on the STOP-Bang scale (APPENDIX II) * History of sedation-related complications in a previous ESP. Exclusion Criteria: * ASA IV patients * Worsening heart failure at the time of the endoscopy or unstable (hospitalized \< 6 months) * Worsening respiratory disease at the time of the endoscopy or unstable (hospitalized \< 6 months) * Pregnant women * Use of home oxygen therapy * Patients with orotracheal intubation * Tracheostomized patients * Patients allergic to or unable to use propofol